Since the US CDC was founded, an unholy alliance has infiltrated public health in the US —euphemistically referred to as “industry/government partnerships” and “Not-for-Profit” government entities —the wicked marriage has infused profit motives into US government agencies charged with regulating medical and pharmaceutical industries.Those involved view themselves as agents working toward a “greater good” —notwithstanding, the trappings of perverse incentives and presumed moral dictates, agencies designed by past generations to protect the US population from harm from corporatist tendencies have been completely captured and subverted. Apologists for regulatory capture even laud the “benefits” of collusion between corporations and the agencies that have been designed —and are funded to —provide regulatory oversight (Reiss, 2011).It seems surreal to consider the brazen use and even celebration of the combination of pharmaceutical influences and matters of state. The “revolving door” between corporations and agencies has been widely recognized for some time –including the FDA (Piller, 2018; Kaplan, 2016), CDC (Reuters, 2009; National Public Radio, 2009).Thirty-nine percent of National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel had tied to Pharmaceutical or Biotechnology companies –this was the committee that recommended the expensive Remdesivir over the inexpensive hydroxychloroquine for treatment of COVID-19.Remdesivir is made by Gilead —and eight of the COVID-19 Treatment Guidelines Panel had ties to Gilead.As well documented as these abuses are, nothing comes of them —even if public health suffers.The scope of its influence on the quality of science that is supposed to inform public health and medical policy is only just now becoming painfully apparent.